4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0000899243-17-028955
Glass John R bought 200,000 shares at an average $0.05 ($10,792)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-12-14 | Purchase : show line 1 in the form | +84,100 | $0.05 | $4,533 | 84,100 | D |
| 2017-12-14 | Purchase : show line 2 in the form | +115,900 | $0.05 | $6,259 | 200,000 | D |
| Open-market purchases · 200,000 sh · avg $0.05 · $10,792 | ||||||
Loading xslF345X03/doc4.xml…